Pentacare Cycle Meet Quiz

20 Questions | Total Attempts: 34

SettingsSettingsSettings
Please wait...
Pentacare Cycle Meet Quiz

.


Questions and Answers
  • 1. 
    What is the required growth to achieve No.1 position in Donepazil combination market?
    • A. 

      40%

    • B. 

      50%

    • C. 

      30%

    • D. 

      35%

  • 2. 
    Objective of Donep is to increase minimum ________ Rxers (Neuros)/ME/HQ
    • A. 

      3

    • B. 

      5

    • C. 

      7

    • D. 

      8

  • 3. 
    As per the marketing presentation, how many average number of docs per HQ prescribe Donepazil & how many Drs Rx Donep? (Including both Neuro+Psy) 
    • A. 

      20 & 15

    • B. 

      15 & 20

    • C. 

      21 & 12

    • D. 

      12 & 21

  • 4. 
    Synergestic action of Donepazil + Memantine combination in moderate to severe AD, is focused in which speciality as per the strategy? 
    • A. 

      Psy

    • B. 

      Neuro

    • C. 

      CPs

    • D. 

      All of the above

  • 5. 
    Identify the right mix of docs we need to focus in increasing the Rxions support for Donep?
    • A. 

      2 rxers & 1 non-rxer

    • B. 

      2 non-rxer & 1 rxer

    • C. 

      2 non-rxer

    • D. 

      1 rxer

  • 6. 
    MCI stands for Moderate Cognitive Impairment
    • A. 

      True

    • B. 

      False

  • 7. 
    _______ & _________ are the inputs for PEL series-2, that we would be distributing.
    • A. 

      Bathing & personal care

    • B. 

      AD & memory test

    • C. 

      Dressing & Oral care

    • D. 

      AD & LBD

  • 8. 
    How many docs we need to convert for developing loyal Rxers for Sizlac?
    • A. 

      3

    • B. 

      4

    • C. 

      5

    • D. 

      7

  • 9. 
    Sample strategy for Sizlac is ___________
    • A. 

      5 drs - 50 units

    • B. 

      4 drs - 40 units

    • C. 

      3 drs - 30 units

    • D. 

      2 drs - 20 units

  • 10. 
    Melzap to be focused with 10 Psy & 15 CPs
    • A. 

      True

    • B. 

      False

  • 11. 
    Identify the right sentence with respect to Melzap
    • A. 

      Contains super disintegrant

    • B. 

      Croscarmellose is the name of the super disintegrant

    • C. 

      Super disintegrant is present in the outer layer of the tablet

    • D. 

      Super disintegrant will swell & cause wicking effect

    • E. 

      All of the above

    • F. 

      A,B & D

  • 12. 
    Expected PMPM for SIzlac is ________
    • A. 

      20K

    • B. 

      30K

    • C. 

      40K

    • D. 

      25K

  • 13. 
    Against which company brands we talk about the size difference with Valkem OD as an advantage. 
    • A. 

      Diva OD & Daya OD

    • B. 

      Depakote & Dicorate ER

    • C. 

      Diva OD & Dicorate ER

    • D. 

      Diva OD & Desval ER

  • 14. 
    Identify the right customer set for Ceham 
    • A. 

      10 Neuros & 5 CPs with ICU

    • B. 

      5 Neuros & 10 CPs with ICU

    • C. 

      5 Neuros & 5 CPs with ICU

    • D. 

      None of the above

  • 15. 
    Which are the SKUs of Neurokem range, where slow growth was seen?
    • A. 

      Neurokem 150mg, M , plus

    • B. 

      Neurokem M, OD, plus

    • C. 

      Neurokem OD, NT, 150mg

    • D. 

      Neurokem 150mg, M, OD

  • 16. 
    Identify the new inputs for Neurokem range
    • A. 

      VR box

    • B. 

      Diagnostic instruments

    • C. 

      NeP PELexercises

    • D. 

      Table top leather planner

    • E. 

      All of the above

  • 17. 
    Expected No of docs conversion for Neurokem range 
    • A. 

      10 CPs & 15 Neuros

    • B. 

      15 Cps & 10 Neuros

    • C. 

      15 Cps & 15 Neuros

    • D. 

      10 CPs & 10 Neuros

  • 18. 
    Patient can save Rs 10 per strip with Migrabeta TR 40mg Vs Betacap TR 40mg
    • A. 

      True

    • B. 

      False

  • 19. 
    Identify the right product for which the activity is done of 5th of June?
    • A. 

      Donep

    • B. 

      Melzap

    • C. 

      Sizlac

    • D. 

      Newcita

  • 20. 
    Identify the right indication for Ceham P 
    • A. 

      TIA

    • B. 

      RCN activity

    • C. 

      Post stroke moderate to severe form of cognitive dysfunction

    • D. 

      Serious cerebral injuries, stroke

Back to Top Back to top